Stay updated on VB-111 Combo in Recurrent Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the VB-111 Combo in Recurrent Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the VB-111 Combo in Recurrent Glioblastoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the funding/status notice (Revision: v3.4.1). These changes do not affect the study content or user interactions on the page.
    Difference
    0.3%
    Check dated 2026-02-11T12:18:35.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a site-wide notice that information may not be up to date due to a lapse in government funding, with guidance to check opm.gov for updates. Updated page revision to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T06:45:53.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added UI element 'Show glossary' and new metadata labels ('Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', 'Revision: v3.4.0'); removed outdated labels ('Last Update Submitted that met QC Criteria', 'No FEAR Act data', 'Revision: v3.3.4').
    Difference
    0.1%
    Check dated 2026-01-28T04:34:39.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The change log shows a minor version update from v3.3.3 to v3.3.4. No changes to study content, navigation, or critical data are evident in the screenshot; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:53:19.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Locations were expanded to include new sites across Alabama, Arizona, California, Colorado, District of Columbia, Florida, Georgia, Illinois, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Missouri, New Hampshire, New York, North Carolina, Pennsylvania, Texas, Utah, Virginia, Washington, Wisconsin, Alberta, and Ontario. The page revision updated to v3.3.3 and the HHS Vulnerability Disclosure link was removed.
    Difference
    2%
    Check dated 2025-12-23T17:16:45.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Publication information now notes that PubMed publications are automatically filled from PubMed and may not be about the study. Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T17:04:27.000Z thumbnail image

Stay in the know with updates to VB-111 Combo in Recurrent Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the VB-111 Combo in Recurrent Glioblastoma Clinical Trial page.